Patent application number | Description | Published |
20080221153 | N3-SUBSTITUTED IMIDAZOPYRIDINE C-KIT INHIBITORS -
Compounds represented by Formula (I):
| 09-11-2008 |
20090023703 | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase - Compounds represented by Formula (I): | 01-22-2009 |
20090221644 | Gpcr Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 09-03-2009 |
20090325924 | GPCR Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 12-31-2009 |
20100267780 | BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS - Compounds of formula (I) or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful inter alia for the treatment of obesity. | 10-21-2010 |
20110059942 | Azetidinyl G-Protein Coupled Receptor Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are agonists of GPR119 and are useful for the treatment of diabetes and as peripheral regulators of satiety, e.g. for the treatment of obesity and metabolic syndrome. | 03-10-2011 |
20110212939 | Heterocyclic GPCR Agonists - Compounds of formula (I) or pharmaceutically acceptable salts thereof, are GPCR (GPR119) agonists and are useful as for the treatment of diabetes and obesity. | 09-01-2011 |
20110269734 | PIPERIDINYL GPCR AGONISTS - Compounds of formula (I):or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of diabetes and obesity. | 11-03-2011 |
20120077793 | Compounds for the Treatment of Metabolic Disorders - The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes. | 03-29-2012 |
20120172358 | GPCR Agonists - Compounds of formula (I): | 07-05-2012 |